TheProfitWatch

NMRA - Neumora Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.81 0.06 (3.31%) --- --- --- --- 0.04 (2.21%) 0.0 (0.0%) 0.0 (0.0%)

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.33
Diluted EPS:
-0.33
Basic P/E:
-5.6667
Diluted P/E:
-5.6667
RSI(14) 1m:
100.0
VWAP:
1.87
RVol:
0.9449

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.82 -0.02 (-1.09%) Oct 15 15:45
1m Price increase 1m 1.87 +0.02 (+1.36%) Oct 15 10:35

Related News